ter Meulen Jan Henrik 4

Accession 0001209191-18-043394

CIK 0001437786other

View on SEC.gov Company Profile

Filed

Jul 18, 8:00 PM ET

Accepted

Jul 19, 6:02 PM ET

Size

22.6 KB

Accession

0001209191-18-043394

Insider Transaction Report

Form 4

Period: 2018-07-17

IMMUNE DESIGN CORP.IMDZ

ter Meulen Jan Henrik

Chief Scientific Officer

Transactions

Disposition to Issuer
Stock Option (Rt to Buy)
2018-07-17−2,493→ 0 total
Exercise: $31.00Exp: 2025-01-07→ Common Stock (2,493 underlying)
Disposition to Issuer
Stock Option (Rt to Buy)
2018-07-17−22,507→ 0 total
Exercise: $31.00Exp: 2025-01-07→ Common Stock (22,507 underlying)
Award
Stock Option (Rt to Buy)
2018-07-17+1,247→ 1,247 total
Exercise: $4.40Exp: 2025-07-17→ Common Stock (1,247 underlying)
Award
Stock Option (rt to Buy)
2018-07-17+3,186→ 3,186 total
Exercise: $4.40Exp: 2025-07-17→ Common Stock (3,186 underlying)
Award
Stock Option (Rt to Buy)
2018-07-17+31,101→ 31,101 total
Exercise: $4.40Exp: 2025-07-17→ Common Stock (31,101 underlying)
Award
Stock Option (Rt to Buy)
2018-07-17+11,254→ 11,254 total
Exercise: $4.40Exp: 2025-07-17→ Common Stock (11,254 underlying)
Disposition to Issuer
Stock Option (Rt to Buy)
2018-07-17−5,574→ 0 total
Exercise: $19.39Exp: 2026-01-04→ Common Stock (5,574 underlying)
Disposition to Issuer
Stock Option (Rt to Buy)
2018-07-17−54,426→ 0 total
Exercise: $19.39Exp: 2026-01-04→ Common Stock (54,426 underlying)

Footnotes (7)

[F1]The option provided for vesting of 1/4th of the shares underlying the option on January 1, 2016 and the remainder of the shares at a rate of 1/36th per month thereafter.
[F2]On July 17, 2018, the issuer canceled, pursuant to the issuer's option exchange program, an option for 2,493 shares of the issuer's common stock granted to the reporting person on January 7, 2015. In exchange, the reporting person received a replacement option, for 1,247 shares, having an exercise price of $4.40 per share.
[F3]The option vests in twenty four (24) equal consecutive monthly installments beginning on August 17, 2018.
[F4]On July 17, 2018, the issuer canceled, pursuant to the issuer's option exchange program, an option for 22,507 shares of the issuer's common stock granted to the reporting person on January 7, 2015. In exchange, the reporting person received a replacement option, for 11,254 shares, having an exercise price of $4.40 per share.
[F5]The option provided for vesting of 1/4th of the shares underlying the option on January 4, 2017 and the remainder of the shares underlying the option at a rate of 1/36th per month thereafter.
[F6]On July 17, 2018, the issuer canceled, pursuant to the issuer's option exchange program, an option for 5,574 shares of the issuer's common stock granted to the reporting person on January 4, 2016. In exchange, the reporting person received a replacement option, for 3,186 shares, having an exercise price of $4.40 per share.
[F7]On July 17, 2018, the issuer canceled, pursuant to the issuer's option exchange program, an option for 54,426 shares of the issuer's common stock granted to the reporting person on January 4, 2016. In exchange, the reporting person received a replacement option, for 31,101 shares, having an exercise price of $4.40 per share.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

IMMUNE DESIGN CORP.

CIK 0001437786

→

Entity typeother

Related Parties

filerCIK 0001606032

Filing Metadata

Form type: 4
Filed: Jul 18, 8:00 PM ET
Accepted: Jul 19, 6:02 PM ET
Size: 22.6 KB

View on SEC.gov